Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex^TM Donepezil Transdermal System at Alzheimer’s Association International Conference^® 2017
MENLO PARK, Calif. , July 18, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced that Parminder “Bobby” Singh , Ph.D., Corium’s…